reaction to stress and infection

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Medicine & Technology Mar 08, 2021

The 40-year-old antidepressant drug, Fluvoxamine is currently being tested as a potential treatment for COVID-19. It has been authorized by the FDA to be considered for those at high risk of suffering severe symptoms of COVID-19.

reaction to stress and infection

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Most Popular

Roman Lead Coffin Found To Hold Previously Unknown Human Child Remains in Fascinating Discovery

Largest Marine Reptile Ever Found? Fossils of Colossal Prehistoric Underwater Species Discovered by Paleontologists

600-Year-Old Voynich Manuscript Cracked; Encrypted Text Includes Censored Information on Sex, Contraception, Gynecology

New York City To Use Birth Control as Humane Option in Reducing Rat Population

Can Animals Count? Scientists Unveil the Neural Basis of Number Sense in Rats

Recommended Stories

NASA Confirms Mysterious Object That Crashed Into Florida Home Was a Space Junk

Mercury-Bound BepiColombo Spacecraft Observes Cold Oxygen and Carbon Ions Escaping the Induced Magnetosphere of Venus

Potentially-Hazardous Asteroid Makes Closest Approach to Earth, Can Be Visible for the First Time Through Amateur Telescopes

Pluto's Heart: Massive Ancient Collision May Explain How Dwarf Planet's Unique Heart-Shaped Feature Formed, Scientists Discover